Alecensaro (alectinib)

pCPA File Number: 21076
Negotiation Status:
Concluded with an LOI
Indication(s):
Non-Small Cell Lung Cancer (First Line)
Sponsor/Manufacturer:
Hoffmann-La Roche
CADTH Project Number:
pCODR 10125
pCPA Engagement Letter Issued:
Negotiation Process Concluded: